Abbott Laboratories
SIX:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
SIX:ABT
Watchlist
Price: 91.0424 CHF -4.17% Market Closed
Market Cap: 239.4B CHF

EV/EBITDA
Enterprise Value to EBITDA

19.9
Current
19.9
Median
12
Industry
Lower than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
19.9
=
Enterprise Value
221.6B USD
/
EBITDA
11.2B USD
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
18.5
2-Years Forward
EV/EBITDA
16.8
3-Years Forward
EV/EBITDA
15.3